| Prev Close: | 87.80 |
|---|---|
| Open: | 87.00 |
| Bid: | 87.26 x 200 |
| Ask: | 87.27 x 700 |
| 1y Target Est: | 86.50 |
| Beta: | 0.48 |
| Next Earnings Date: | 15-Jul-13 |
| Day's Range: | 87.00 - 87.79 |
|---|---|
| 52wk Range: | 61.71 - 89.99 |
| Volume: | 2,813,164 |
| Avg Vol (3m): | 9,786,560 |
| Market Cap: | 245.86B |
| P/E (ttm): | 23.70 |
| EPS (ttm): | 3.68 |
| Div & Yield: | 2.64 (3.00%) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- J&J: We're Creaming Medivation, Boehringer, Bristol And Pfizerat Forbes(Thu 9:46AM EDT)
- New Stock Coverage: Can Johnson & Johnson Be Market's Band-Aid?at Minyanville(Thu 9:25AM EDT)
- J&J forecasts 10 new drug applications by 2017AP(Thu 8:31AM EDT)
- J&J plans filing on more than 10 new drugs by 2017at Reuters(Thu 8:30AM EDT)
- Workday's Loss Narrows in 1QZacks(Thu 8:30AM EDT)
- Johnson & Johnson plans on more than 10 drugs filed by 2017at Reuters(Thu 7:56AM EDT)
- J&J Sees 10 Products Submitted For Approval by 2017at Bloomberg(Thu 7:39AM EDT)
- InPlay: Johnson & Johnson pharmaceuticals segment poised to continue driving growth with more than 10 potential new product filings by 2017Briefing.com(Thu 7:36AM EDT)
- Janssen expects to have more than 25 brand line extensions by 2017at theflyonthewall.com(Thu 7:31AM EDT)
- Johnson & Johnson Pharmaceuticals Segment Poised to Continue Driving Growth with More than 10 Potential New Product Filings by 2017PR Newswire(Thu 7:30AM EDT)
- Johnson & Johnson: At The Crossroads - Part IV - One Road To Higher Profit Growth Ratesat Seeking Alpha(Thu 6:30AM EDT)
- Johnson & Johnson coverage assumed with an Underperform at Credit Suissetheflyonthewall.com(Thu 6:29AM EDT)
- Can Financial Innovation Unlock a Cure for Cancer?at Motley Fool(Wed May 22)
- Final Glance: Medical Devices companiesAP(Wed May 22)
- Final Glance: Pharmaceuticals companiesAP(Wed May 22)
Press Releases
- Investment Ideas in the Expanding Wound Care MarketAccesswire(Fri May 17)
- StockCall Scrutinizes PFE, MRK, JNJ, ABBV, and ZGNXAccesswire(Wed May 15)
- Traders’ Favorite: National Bank of Greece, EMC Corporation, BioCryst PharmaceuticalsAccesswire(Mon Apr 8)
Must Read
- 80-year-old Japanese extreme skier becomes oldest climber to reach summit of Mount EverestThe Canadian Press(Thu 6:04AM EDT)
- TSX, U.S. index drop as world markets plunge on bad Chinese data, Fed commentsThe Canadian Press(Thu 5:44AM EDT)
- Ralph Lauren's 4Q profit rises 35 pct, but posts sales shortfallThe Canadian Press(Thu 5:41AM EDT)
- Cooling housing market will cost us 150,000 jobsCBC(Thu 5:06AM EDT)
- Marathon Oil: talks tied to sale of part of stake in Athabasca Oil Project have endedThe Canadian Press(Thu 5:06AM EDT)